Now Testing Wastewater for COVID-19

Learn more

Company / News & Insights / Delivering Science Better; Advancing Novel Therapies Through the Clinic to Commercialization

Delivering Science Better; Advancing Novel Therapies Through the Clinic to Commercialization

Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM

Drug Development and Delivery recently interviewed our very own, Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM at Pace Analytical® Life Sciences (PLS). After two recent acquisitions, Pace now operates five state-of-the-art facilities, and is well-equipped to handle almost any project regardless of scope or complexity. Investing in the right scientists, facilities, and technologies has allowed Pace to anticipate the science that will become the basis of the next round of therapies.

Read the full article for Frank’s thoughts on the industry and where Pace may be headed in the future.